229 related articles for article (PubMed ID: 33112125)
1. Antiplatelet and anticoagulation therapy after revascularization for lower extremity artery disease: a national survey and literature overview.
Ipema J; Brand AR; DE Borst GJ; DE Vries JP; ÜnlÜ Ç
J Cardiovasc Surg (Torino); 2021 Feb; 62(1):59-70. PubMed ID: 33112125
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
[TBL] [Abstract][Full Text] [Related]
3. Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention.
Singh N; Ding L; Magee GA; Shavelle DM; Kashyap VS; Garg PK
Circ Cardiovasc Interv; 2020 Aug; 13(8):e008791. PubMed ID: 32791948
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy in Lower Extremity Artery Disease.
Vrsalovic M; Aboyans V
Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
[TBL] [Abstract][Full Text] [Related]
5. Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventions.
Kim TI; Chen JF; Orion KC
Vasc Med; 2019 Dec; 24(6):528-535. PubMed ID: 31686603
[TBL] [Abstract][Full Text] [Related]
6. Selective Use of Anticoagulation or Dual Antiplatelet Therapy for Patients with Extra-anatomic Bypasses.
Teveris V; Columbo J; Bartline P; Goodney P; Stone D; Suckow B
Ann Vasc Surg; 2020 Jul; 66():272-281.e1. PubMed ID: 31931126
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic treatment in peripheral artery disease.
Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic Therapy for Peripheral Revascularisation.
De Carlo M; Angelillis M; Liga R
Curr Vasc Pharmacol; 2020; 18(3):223-236. PubMed ID: 30727899
[TBL] [Abstract][Full Text] [Related]
10. Prime Time for Lower Extremity Artery Disease.
De Carlo M
Curr Vasc Pharmacol; 2020; 18(3):201-203. PubMed ID: 32340598
[No Abstract] [Full Text] [Related]
11. A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
Tangelder MJ; Nwachuku CE; Jaff M; Baumgartner I; Duggal A; Adams G; Ansel G; Grosso M; Mercuri M; Shi M; Minar E; Moll FL
J Endovasc Ther; 2015 Apr; 22(2):261-8. PubMed ID: 25809373
[TBL] [Abstract][Full Text] [Related]
12. A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization.
McClure GR; Kaplovitch E; Chan N; Bhagirath V; Harlock J; Szalay D; Anand SS
Can J Cardiol; 2021 Mar; 37(3):504-507. PubMed ID: 32585326
[TBL] [Abstract][Full Text] [Related]
13. Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
Warlé-Van Herwaarden MF; Roukens M; Pop GA; Lamfers EJ; De Smet PA; Kramers C
Eur J Prev Cardiol; 2014 Feb; 21(2):231-43. PubMed ID: 22684153
[TBL] [Abstract][Full Text] [Related]
14. Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia.
Marcaccio CL; Patel PB; Wang S; Rastogi V; Moreira CC; Siracuse JJ; Schermerhorn ML; Stangenberg L
J Vasc Surg; 2022 May; 75(5):1696-1706.e4. PubMed ID: 35074410
[TBL] [Abstract][Full Text] [Related]
15. [Clinical practice of dual antiplatelet therapy after percutaneous peripheral arterial interventions in Germany].
Baumhäkel M; Kindermann M
Dtsch Med Wochenschr; 2016 Jan; 141(2):e24-31. PubMed ID: 26800077
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease.
Beiswenger AC; Jo A; Harth K; Kumins NH; Shishehbor MH; Kashyap VS
J Vasc Surg; 2018 Jun; 67(6):1922-1932.e6. PubMed ID: 29801560
[TBL] [Abstract][Full Text] [Related]
17. Perioperative prophylactic antithrombotic strategies in vascular surgery: current practice in the Netherlands.
Wiersema A; Bruijninckx C; Reijnen M; Vos J; Van Delden O; Vahl A; Zeebregts C; Moll F
J Cardiovasc Surg (Torino); 2015 Feb; 56(1):119-25. PubMed ID: 23337406
[TBL] [Abstract][Full Text] [Related]
18. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
[TBL] [Abstract][Full Text] [Related]
19. Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial.
Moll F; Baumgartner I; Jaff M; Nwachuku C; Tangelder M; Ansel G; Adams G; Zeller T; Rundback J; Grosso M; Lin M; Mercur MF; Minar E;
J Endovasc Ther; 2018 Apr; 25(2):158-168. PubMed ID: 29552984
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
